How May Proton Pump Inhibitors Impair Cardiovascular Health?
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 3, p. 153, doi. 10.1007/s40256-016-0160-9
- By:
- Publication type:
- Article
Works matching IS 11753277 AND DT 2016 AND VI 16 AND IP 3
Results: 6
1
2
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 3, p. 183, doi. 10.1007/s40256-016-0161-8
- By:
- Publication type:
- Article
3
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options.
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 3, p. 163, doi. 10.1007/s40256-016-0162-7
- By:
- Publication type:
- Article
4
Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 3, p. 171, doi. 10.1007/s40256-016-0163-6
- By:
- Publication type:
- Article
5
Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 3, p. 201, doi. 10.1007/s40256-016-0164-5
- By:
- Publication type:
- Article
6
Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 3, p. 221, doi. 10.1007/s40256-016-0168-1
- By:
- Publication type:
- Article